Vanguard Global Advisers »

Impact Biomedical shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Impact Biomedical (IBO) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Impact Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Impact Biomedical held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Impact Biomedical by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $19k 32k 0.60

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Impact Biomedical

Geode Capital Management
Vanguard Group
Vanguard Capital Management
Vanguard Fiduciary Trust
BlackRock
Two Sigma Investments
UBS Group
Vanguard Global Advisers
Susquehanna International
State Street Corporation
Northern Trust
Mason & Associates
Morgan Stanley
Global Trust Asset Management
Tower Research Capital

View all funds holding Impact Biomedical